ocucoat

Formulated from a 2% hydroxypropyl methylcellulose solution, OcuCoat Viscoelastic is excellent for high-volume, small-incision cataract surgery. It can be used for a variety of applications as an ophthalmic surgical aid in anterior segment surgical procedures, including cataract extraction and intraocular lens implantation.

Key Features & Benefits

  • 1.0 mL Preloaded sterile glass syringe
  • No refrigeration
  • Minimal effect on IOP
  • Highly lubricious
  • Latex-free formulation

OcuCoat Order Information:

Contact your Bausch + Lomb Sales Representative or call 1-800-338-2020 to order.

 Size    

 Part Number

 1.0 mL x 6

 CC065S

 1.0 mL

 CC050S

INDICATIONS AND SAFETY INFORMATION

INDICATIONS: OcuCoat Viscoelastic is indicated for use as an ophthalmic surgical aid in anterior segment surgical procedures, including cataract extraction and intraocular lens implantation. OcuCoat maintains a deep chamber during anterior segment surgery and thereby allows for more efficient manipulation with less trauma to the corneal endothelium and other ocular tissues.

PRECAUTIONS: For intraocular use only. Discard unused contents of OcuCoat syringe after each use. Do not resterilize.

Precautions are limited to those normally associated with the ophthalmic surgical procedure being performed. There may be transient increased intraocular pressure following surgery because of pre-existing glaucoma or due to the surgery itself. For these reasons, the following precautions should be considered:

  • OcuCoat should be removed from the anterior chamber at the end of surgery
  • If the post-operative intraocular pressure increases above expected values, appropriate therapy should be administered

ADVERSE EVENTS: Clinical testing of OcuCoat showed it to be extremely well tolerated after injection into the human eye.

A transient rise in intraocular pressure postoperatively has been reported in some cases.

Rarely, postoperative inflammatory reactions (iritis, hypopyon), as well as incidents of corneal edema and corneal decompensation, have been reported with viscoelastic agents. Their relationship to OcuCoat has not been established.

ATTENTION: Refer to the Directions for Use labeling for a complete listing of indications, warnings and precautions, clinical trial information, etc.

CAUTION: Federal (USA) law restricts this device to the sale by or on the order of a physician.

OCT.0014.USA.18